This follows KKR's recent acquisition of a controlling stake in medical device maker Healthium.KKR's portfolio also includes JB Pharma, Infinx, and PHC, further solidifying its presence in this rapidly growing market. Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
